2. Immunology/Inflammation NF-κB Metabolic Enzyme/Protease
  3. Reactive Oxygen Species (ROS)
  4. 2α-Ferrocenylmethyl-DHT

2α-Ferrocenylmethyl-DHT is a dihydrotestosterone-derived ferrocene-steroid conjugate. 2α-Ferrocenylmethyl-DHT inhibits the growth of various cancer cells. 2α-Ferrocenylmethyl-DHT induces S-phase cell cycle arrest in ovarian cancer cells, elevates intracellular iron levels, triggers ROS-dependent cell death, and disrupts the integrity of multicellular tumor spheroids of ovarian cancer cells. 2α-Ferrocenylmethyl-DHT can be used in the research of prostate cancer and ovarian cancer.

For research use only. We do not sell to patients.

2α-Ferrocenylmethyl-DHT

2α-Ferrocenylmethyl-DHT Chemical Structure

Size Stock
50 mg   Get quote  
100 mg   Get quote  
250 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

2α-Ferrocenylmethyl-DHT Related Antibodies

Top Publications Citing Use of Products

  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

2α-Ferrocenylmethyl-DHT is a dihydrotestosterone-derived ferrocene-steroid conjugate. 2α-Ferrocenylmethyl-DHT inhibits the growth of various cancer cells. 2α-Ferrocenylmethyl-DHT induces S-phase cell cycle arrest in ovarian cancer cells, elevates intracellular iron levels, triggers ROS-dependent cell death, and disrupts the integrity of multicellular tumor spheroids of ovarian cancer cells. 2α-Ferrocenylmethyl-DHT can be used in the research of prostate cancer and ovarian cancer[1].

In Vitro

2α-Ferrocenylmethyl-DHT (Compound 2) (3.12-50 μM; 72 h) potently inhibits the growth of OVCAR-3 (IC50 = 2.8 μM), PC-3 (IC50 = 16.8 μM), LNCaP (IC50 = 16 μM) cancer cells and non-malignant MRC-5 fibroblasts (IC50 = 8.5 μM), and exhibits moderate tumor selectivity toward OVCAR-3 cells[1].
2α-Ferrocenylmethyl-DHT (2.8 μM; 48 h, 72 h) induces time-dependent S-phase arrest in OVCAR-3 cells, with extremely low accumulation of Sub-G1 phase cells[1].
Treatment with 2α-Ferrocenylmethyl-DHT (50 μM; 24 h) increases intracellular iron levels in OVCAR-3 cells by 21-fold[1].
2α-Ferrocenylmethyl-DHT (0.3-30 μM; 72 h) induces ROS-dependent, caspase-independent cell death in OVCAR-3 cells[1].
2α-Ferrocenylmethyl-DHT (3.12-50 μM; 72 h) disrupts the integrity and inhibits the growth of OVCAR-3 multicellular tumor spheroids, with an IC50 of 14 μM[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

2α-Ferrocenylmethyl-DHT Related Antibodies

Cell Proliferation Assay[1]

Cell Line: human prostate adenocarcinoma PC-3 cells, LNCaP cells, ovarian adenocarcinoma OVCAR-3 cells, non-malignant MRC-5 fetal lung fibroblasts
Concentration: 3.12, 6.25, 12.5, 25, 50 μM
Incubation Time: 72 h
Result: Inhibited PC-3 cell growth with an IC50 of 16.8 μM.
Inhibited LNCaP cell growth with an IC50 of 16 μM.
Inhibited OVCAR-3 cell growth with an IC50 of 2.8 μM.
Inhibited MRC-5 cell growth with an IC50 of 8.5 μM.
Achieved a selectivity index of 3.03 for OVCAR-3 cells relative to MRC-5 cells.

Cell Cycle Analysis[1]

Cell Line: human ovarian adenocarcinoma OVCAR-3 cells
Concentration: 2.8 μM
Incubation Time: 48 h; 72 h
Result: Increased S-phase population to 24.1=% after 72 h, compared to 10=% in untreated controls.
Reduced G1 phase population and elevated G2/M phase population after 72 h.
Increased Sub-G1 fraction to 9.3% after 72 h.

Cell Proliferation Assay[1]

Cell Line: 3D multicellular tumor spheroids (MCTSs) of human ovarian adenocarcinoma OVCAR-3 cells
Concentration: 3.12, 6.25, 12.5, 25, 50 μM
Incubation Time: 72 h
Result: Inhibited OVCAR-3 MCTS growth with an IC50 of 14 μM.
Induced weakening of intercellular contacts and loss of spheroid compactness starting at 6.25 μM.
Caused complete loss of spheroid architecture at 50 μM.
Molecular Weight

472.48

Formula

C30H40FeO
SMILES

C[C@]1(C/2)[C@](CC[C@]3([H])[C@]1([H])CC[C@@]4(C)[C@@]3([H])CC[C@@H]4O)([H])CCC2=C\c5cccc5.[][Fe][].c6cccc6
Shipping

Room temperature in continental US; may vary elsewhere.
Storage

Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.

2α-Ferrocenylmethyl-DHT Related Classifications

  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

2α-Ferrocenylmethyl-DHTReactive Oxygen Species (ROS)ferrocene-steroid conjugateOVCAR-3 cellsPC-3cellsLNCaP cellsMRC-5cellsprostate cancerovarian cancerInhibitorinhibitorinhibit

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

  

Requested Quantity *

Applicant Name *

 

Salutation

Email Address *

 

Phone Number *

Department

 

Organization Name *

City

State

Country or Region *

      

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
2α-Ferrocenylmethyl-DHT
Cat. No.:
HY-181688
Quantity:
MCE Japan Authorized Agent:

Customer Review

Thank You for Your Feedback!

Request for HNMR Report

Please fill out this form to request the QC report. We will send it to your Email address shortly.

Your information is safe with us. * Required Fields.

Product Name

  

Lot #

Applicant Name *

 

Email Address *

Phone Number

 

Department *

Organization Name *

 

Country or Region *

Remarks

SAFETY DATA SHEET (SDS)

Request for HNMR Report

We have received your request and will respond to you as soon as possible.